Emory's vaccine and treatment testing program
Vaccine and Treatment Evaluation Units
This program tests vaccines and treatments for infectious diseases like anthrax in adults at Emory and partner clinics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11241958 on NIH RePORTER |
What this research studies
You would take part in clinical trials where participants receive candidate vaccines or treatments and medical teams collect health information and blood samples to see how the body responds. Emory's unit uses clinic, laboratory, and pharmacy space and enrolls adults at Atlanta sites and sometimes at partner locations abroad. Staff closely monitor safety, record side effects, and run lab tests to measure immune responses and protection. The program can also expand quickly to test interventions during outbreaks or biodefense needs.
Who could benefit from this research
Good fit: Ideal candidates are adults (often 21 years and older) who are healthy volunteers or who meet trial-specific criteria for infectious disease or anthrax-related vaccine or treatment studies.
Not a fit: Children, people unable to travel to participating clinics, or those with medical conditions that exclude them from a specific trial may not be eligible or likely to benefit directly.
Why it matters
Potential benefit: If successful, this work could bring safer and more effective vaccines and treatments to people faster and improve preparedness for outbreaks.
How similar studies have performed: The Emory VTEU has run many trials and contributed to responses for pandemic influenza, Zika, and Ebola, so this model has an established track record.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Rouphael, Nadine Georges — Emory University
- Study coordinator: Rouphael, Nadine Georges
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.